1234

Society of Cannabis Clinicians

Educating Healthcare Professionals
About the Medical Use of Cannabis

Learn More Join

Who We Are

The SCC is a nonprofit educational and scientific society of healthcare professionals and allies dedicated to advancing research and disseminating knowledge about medical cannabis.

Read On

Physician Locator Map

Are you looking for a cannabis-knowledgable physician? Are you a healthcare provider wanting to highlight your practice? Our Locator Map guides prospective patients to clinician members.

Take a look

Research Library

The SCC supports the practice of evidence-based cannabinoid medicine. All articles in the collection have been vetted to ensure only rigorous, unbiased, and non-commercialized studies are included.

Learn more

COURSE OFFERINGS

The SCC’s new Clinical Training Curriculum offers education missing from most health professional schools and clinical programs. The curriculum brings hands-on practical guidance on how to develop personalized treatment regimens and more. Continuing education courses enable clinicians to stay up-to-date on emerging topics to ensure patients are receiving the best possible treatment. Scholarships are available, learn more here.

Explore the Courses

Latest News

Does Cannabis Cause Heart Failure and Stroke?

Written by SCC Board Member, Dr. Dustin Sulak Originally posted on Healer at https://healer.com/blog/does-cannabis-cause-heart-failure-and-stroke/ Over…
,

Broad-Spectrum Antiviral Effect of Cannabidiol Against Enveloped and Nonenveloped Viruses

Cannabidiol (CBD), the main non-psychoactive cannabinoid of the Cannabis sativa plant, is a powerful antioxidant compound that in recent years has increased interest due to causes effects in a wide range of biological functions. Zika virus (ZIKV) is a virus transmitted mainly by the Aedes aegypti mosquitoes, which causes neurological diseases, such as microcephaly and Guillain-Barre syndrome. Although the frequency of viral outbreaks has increased recently, no vaccinations or particular chemotherapeutic treatments are available for ZIKV infection. The major aim of this study was to explore the in vitro antiviral activity of CBD against ZIKV, expanding also to other dissimilar viruses.
, ,

The highs and the lows: Recreational marijuana laws and mental health treatment

Recreational marijuana laws (RMLs) continue to grow in popularity, but the effects on mental health treatment are unclear. This paper uses an event-study within a difference-in-differences framework to study the short-run impact of state RMLs on admissions into mental health treatment facilities. The results indicate that shortly after a state adopts an RML, they experience a decrease in the average number of mental health treatment admissions. The findings are driven by white, Black, and Medicaid-funded admissions and are consistent for both male and female admissions. The results are robust to alternative specifications and sensitivity analysis.

Middle School Cannabis Curriculum

SCC Member, Dave Gordon MD, was recently invited to review a middle school cannabis curriculum. Read below to see how education for this population has evolved since the DARE Program days.

Medical Cannabis Science & Therapeutics Masters Program Commencement Ceremony

It is with great honor and pride that we share that our SCC Board Member, Dr. Patricia Frye, on the 17th of May 2023, gave…
, , ,

Antiviral activities of hemp cannabinoids

Hemp is an understudied source of pharmacologically active compounds and many unique plant secondary metabolites including more than 100 cannabinoids. After years of legal restriction, research on hemp has recently demonstrated antiviral activities in silico, in vitro, and in vivo for cannabidiol (CBD), Δ9-tetrahydrocannabinol (Δ9-THC), cannabidiolic acid (CBDA), cannabigerolic acid (CBGA), and several other cannabinoids against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), human immunodeficiency virus (HIV), and γ-herpes viruses. Mechanisms of action include inhibition of viral cell entry, inhibition of viral proteases, and stimulation of cellular innate immune responses. The anti-inflammatory properties of cannabinoids are also under investigation for mitigating the cytokine storm of COVID-19 and controlling chronic inflammation in people living with HIV. Retrospective clinical studies support antiviral activities of CBD, Δ9-THC, and cannabinoid mixtures as do some prospective clinical trials, but appropriately designed clinical trials of safety and efficacy of antiviral cannabinoids are urgently needed.
21 years

As an organization

38 States

Members practice in

24 Countries

Our members represent

737 Articles

in the Research Library

Membership & Online Learning

Link to: Continuing Education

Continuing Education

Study the science and clinical applications of medical cannabis with a focus on the endocannabinoid system, delivery, and dosage. Continuing education courses enable clinicians to stay up-to-date on emerging topics to ensure patients are receiving the best possible treatment.

Link to: Membership

Goals

This year marks our 21st anniversary as a nonprofit organization advocating for doctor and patient rights. Our goal is to develop continuing education for healthcare professionals and share resources we learned and gathered in our collective years of experience.

Membership information

Diversity within the SCC is critical to our success and ability to educate each other. Healthcare professionals and allies are welcome to join, including (but not limited to): physicians, nurses, pharmacists, caregivers, veterinarians, herbalists, physical therapists, researchers, and patients.

Join

Video Library

View our robust collection of presentations by leading international experts sharing cannabis science and medical applications. There are various free options available to everyone. Full videos of quarterly meetings and other exclusive content is viewable in the Members Portal.

Our Videos

O’Shaughnessy’s Journal

SCC Founder Tod Mikuriya, MD was a physician, researcher, and creator of a new “Cannabis Clinician” specialty. Tod envisioned a journal where clinicians monitoring patients’ cannabis use could share observations. O’Shaughnessy’s continues to this day.

Learn more

Global Impact

Affiliates & Allies

Join our email list for access to the latest clinical research and discounts on emerging cannabinoid education